The complex crosstalk and cellular signaling cascades between the PI3K-AKT or AMPK pathway and the Wnt/β-catenin pathway to further promote cancer progression and develop drug resistance have been explored (Khan et al., 2020; Shorning, Dass & Smalley, 2020), but a detailed explanation was missing in this study. The gene discussed is AKT1; the disease is cancer.